Anastasiia O. Sosnovtseva

Systemic and local immunosuppression in glioblastoma and its prognostic significance

Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov et al. · Frontiers in Immunology · 2024 · 31 citations · Full text

Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures

Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov et al. · Molecular Therapy — Oncolytics · 2021 · 26 citations · Full text

Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”

Dmitry S. Karpov, Anastasiia O. Sosnovtseva, Svetlana V. Pylina et al. · International Journal of Molecular Sciences · 2023 · 25 citations · Full text

Insulin Replacement Therapy, Engineering, Immunology +23

Aberrant Splicing of INS Impairs Beta-Cell Differentiation and Proliferation by ER Stress in the Isogenic iPSC Model of Neonatal Diabetes

Alexandra V. Panova, Natalia V. Klementieva, Anna V. Sycheva et al. · International Journal of Molecular Sciences · 2022 · 18 citations · Full text

Induced Pluripotent Stem Cell, Developmental Biology, Isogenic Ipsc Model +12

A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation

Aleksei A. Stepanenko, Anastasiia O. Sosnovtseva, M. P. Valikhov · Scientific Reports · 2021 · 17 citations · Full text